Evidence map›Paper›PMID 34027899›Full record

ArticleJCI insight2021

Pancreatic β cell-selective zinc transporter 8 insufficiency accelerates diabetes associated with islet amyloidosis.

Jie Xu, Nadeeja Wijesekara, Romario Regeenes, Dana Al Rijjal, Anthony L Piro, Youchen Song, Anne Wu, Alpana Bhattacharjee, Ying Liu, Lucy Marzban and 5 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. PARN Maintains RNA Stability to Regulate Insulin Maturation and GSIS in Pancreatic β Cells.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Review
  7. Impact of anFrontiers in endocrinology · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Multiomics Integrated Analysis IdentifiesJournal of diabetes research · 2022
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Jie XuShanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Diseases, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Nadeeja WijesekaraTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto Western Hospital, Toronto, Ontario Canada.
Romario RegeenesInstitute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
Dana Al RijjalDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Anthony L PiroDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Youchen SongDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Anne WuDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Alpana BhattacharjeeDivision of Advanced Diagnostics, Toronto General Hospital Research Institute, Toronto General Hospital, Toronto, Ontario, Canada.
Ying LiuDivision of Advanced Diagnostics, Toronto General Hospital Research Institute, Toronto General Hospital, Toronto, Ontario, Canada.
Lucy MarzbanCollege of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Jonathan V RocheleauDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Paul E FraserTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto Western Hospital, Toronto, Ontario Canada.
Feihan F DaiDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Cheng HuShanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Diseases, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Michael B WheelerDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
University of Toronto · CAShanghai Jiao Tong University · CNToronto General Hospital · CAToronto Western Hospital · CAUniversity Health Network · CAUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GWAS have shown that the common R325W variant of SLC30A8 (ZnT8) increases the risk of type 2 diabetes (T2D). However, ZnT8 haploinsufficiency is protective against T2D in humans, counterintuitive to earlier work in humans and mouse models. Therefore, whether decreasing ZnT8 activity is beneficial or detrimental to β cell function, especially under conditions of metabolic stress, remains unknown. In order to examine whether the existence of human islet amyloid polypeptide (hIAPP), a coresident of the insulin granule, affects the role of ZnT8 in regulating β cell function, hIAPP-expressing transgenics were generated with reduced ZnT8 (ZnT8B+/- hIAPP) or null ZnT8 (ZnT8B-/- hIAPP) expression specifically in β cells. We showed that ZnT8B-/- hIAPP mice on a high-fat diet had intensified amyloid deposition and further impaired glucose tolerance and insulin secretion compared with control, ZnT8B-/-, and hIAPP mice. This can in part be attributed to impaired glucose sensing and islet cell synchronicity. Importantly, ZnT8B+/- hIAPP mice were also glucose intolerant and had reduced insulin secretion and increased amyloid aggregation compared with controls. These data suggest that loss of or reduced ZnT8 activity in β cells heightened the toxicity induced by hIAPP, leading to impaired β cell function and glucose homeostasis associated with metabolic stress.

Indexed as

Zinc Transporter 8AmyloidosisAnimalsDiabetes Mellitus, Type 2Disease Models, AnimalHumansInsulin-Secreting CellsIslet Amyloid PolypeptideMaleMiceMice, TransgenicIslet Amyloid PolypeptideSLC30A8 protein, humanZinc Transporter 8Beta cellsDiabetesEndocrinologyInsulinMetabolism

Identifiers

PMID34027899
PMCPMC8262350
OpenAlexW3165164478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.